Long COVID with Symptoms Persisting for More than Six Months in Unvaccinated Patients: Investigation of Biochemical Changes Associated with Chronic Manifestations
Authors:
- Matheus TorresMatheus Torres
- Giulia DavançoGDGiulia Davanço
- Isabela de Paula DestroIDIsabela de Paula Destro
- Neif MuradNMNeif Murad
- Glaucia Luciano da VeigaGVGlaucia Luciano da Veiga
- Pedro Henrique Alves ReisPRPedro Henrique Alves Reis
- Renata de Lion Botero MartinsRMRenata de Lion Botero Martins
- Beatriz da Costa Aguiar AlvesBABeatriz da Costa Aguiar Alves
- Rodrigo Daminello RaimundoRRRodrigo Daminello Raimundo
- Juliana Zangirolami-RaimundoJZJuliana Zangirolami-Raimundo
- Fernando Luiz Affonso FonsecaFFFernando Luiz Affonso Fonseca
Open Access
Abstract
Long COVID is a complex condition characterized by persistent symptoms following SARS-CoV-2 infection. Understanding its biochemical mechanisms is essential for effective management and treatment strategies. Objective: This study investigated biochemical alterations associated with long COVID in unvaccinated individuals presenting symptoms persisting for more than six months, highlighting the prolonged nature of the condition and its systemic and neurological manifestations. A cross-sectional study was conducted with 60 unvaccinated patients at least six months post-COVID-19 infection. Serum biomarkers, including C-reactive protein (CRP), interleukin-6 (IL-6), N-terminal pro-brain natriuretic peptide (NT-proBNP), and irisin, were analyzed. Correlations between these biomarkers and persistent symptoms were assessed using statistical regression models. Elevated CRP levels were significantly associated with persistent respiratory and musculoskeletal symptoms, suggesting ongoing inflammation. Increased IL-6 levels correlated with fatigue and musculoskeletal complaints. NT-proBNP elevations were linked to cardiovascular manifestations, including dyspnea and chest pain. A positive correlation between irisin and persistent sensory impairments, such as anosmia and dysgeusia, indicates potential neuroinflammatory mechanisms. This study highlights that persistent inflammation plays a critical role in long-term (>6 months) post-COVID manifestations. Monitoring biomarkers such as CRP, IL-6, NT-proBNP, and irisin may enhance understanding and management of prolonged post-COVID conditions.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (#2021/15162-2)
This publication has 58 references indexed in Scilit:
- Estimated Effectiveness of the BNT162b2 XBB Vaccine Against COVID-19JAMA Internal Medicine, 2024
- NT-proBNP course during MIS-C post-COVID-19: an observational studyEuropean Journal of Pediatrics, 2024
- The Impact of COVID-19 and Pandemic Mitigation Measures on Persons With Sensory ImpairmentAmerican Journal of Ophthalmology, 2022
- Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysisBrain, Behavior, and Immunity, 2021
- Serum troponin, D‐dimer, and CRP level in severe coronavirus (COVID‐19) patientsImmunity, Inflammation and Disease, 2021
- The impact of COVID‐19 lockdown on brain metabolismHuman Brain Mapping, 2021
- 18F-FDG brain PET hypometabolism in patients with long COVIDEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital DischargeJAMA Network Open, 2021
- Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly populationSeminars in Immunopathology, 2020
- Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19)The Journal of Pathology, 2020